Metin Kurtoglu

Dr. Kurtoglu is the company’s Chief Operating Officer. His clinical and basic science research career spans over 20 years and has focused on developing novel targets for drug-resistant cancer cells and cancer stem cells, including multiple myeloma. He has also been an investigator in various cancer immunotherapy trials. Dr. Kurtoglu is a medical oncologist board certified in internal medicine and completed his residency and graduate training at the University of Miami, and clinical and research fellowship at the NCI / NIH.